Global 3D Bioprinting Research Report 2017: Short Term Forecast to 2021 & Overall Forecast to 2027 - Technologies, Markets, Forecasts - ResearchAndMarkets.com

DUBLIN — (BUSINESS WIRE) — January 30, 2018 — The "3D Bioprinting 2017-2027: Technologies, Markets, Forecasts" report has been added to ResearchAndMarkets.com's offering.

This report forecasts the overall 3D bioprinting market to 2027, with in depth discussion of key trends in the short term (2017 - 2021), and those expected in the long term (2022 - 2027). Market forecasts to 2027 are also provided for the 3D bioprinter market segmented by price point, and the 3D bioprinted tissue market segmented by tissue application.

This report profiles each technology and its subtypes, and provides key specifications, vendors, and SWOT analyses. This report also introduces and discusses emerging 3D bioprinting technologies of electrospinning, optical bioprinting, label-less magnetic levitation, and acoustic levitation. Technologies and considerations relevant to the 3D bioprinting process, such as software, bioink (including cell selection, growth factors, and scaffold materials), and post-printing maturation are also discussed.

Current and future applications for 3D bioprinting discussed in this report include:

  • Testing of cosmetics and other consumer goods
  • Drug screening
  • Personalised medicine
  • Regenerative medicine
  • Cell-based biosensors
  • Food and other animal products
  • Education
  • Academic research
  • Bionics

Regenerative Medicine

Special attention is paid to regenerative medicine in this report, as not only does it have the potential to be the largest application for 3D bioprinting in the future, but also one with the highest impact.

This report analyses how 3D bioprinting can be applied to regenerative medicine, and focuses on the following tissue types:

  • Bone and cartilage
  • Skin
  • Dental
  • Vasculature
  • Complex organs

Additionally, discussion of current progress in bringing 3D bioprinted tissues to the clinic is provided, as well future hurdles to be faced. A roadmap of 3D bioprinting in regenerative medicine to the year 2050 is provided.

Key Topics Covered:

1. EXECUTIVE SUMMARY

1.1. Overview

1.2. 3D Bioprinting Players

1.3. High Profile Partnerships

1.4. Successful Animal Tests

1.5. 3D Bioprinting Market Forecast 2017 - 2027

1.6. 3D Bioprinter Market Forecast 2017 - 2027

1.7. 3D Bioprinted Tissue Market Forecast 2017 - 2027

2. INTRODUCTION

2.1. Report Scope/3D Bioprinting Definition

2.2. 3D Bioprinting Process

2.3. 3D Cell Culture Advantages

2.4. 3D Bioprinting Advantages

2.5. Key Driver: Regenerative Medicine

2.6. Key Driver: Product Testing in Medicine

2.7. Key Driver: Product Testing in Consumer Products

2.8. Major Bioprinting Firsts

2.9. 3D Bioprinting in 2017

2.10. Key Trends: 3D Bioprinters

2.11. Key Trends: Bioprinted Tissues

2.12. Key Competing Technologies

2.13. Current Technical Challenges

2.14. Current Biological Challenges

2.15. Regulatory Hurdles

2.16. 3D Bioprinting SWOT Analysis

3. 3D BIOPRINTER TECHNOLOGIES

3.1. From 3D Printing to 3D Bioprinting

3.2. 3D Bioprinting Technologies

3.3. 3D Bioprinting Technology Comparison

3.4. Inkjet: Introduction

3.5. Extrusion: Introduction

1 | 2  Next Page »



Review Article Be the first to review this article



© 2018 Internet Business Systems, Inc.
25 North 14th Steet, Suite 710, San Jose, CA 95112
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise